Study summary

The purpose of this study is to evaluate the safety, tolerability, and efficacy of isavuconazonium sulfate in pediatric participants.

Additional Study Details

Phase
Phase 2
Product
N/A
Product
Isavuconazonium sulfate
Type
Interventional
Masking
None (Open Label)
Enrollment number
30
Show Additional Study Details

Get more information

Would you like more information about clinical trial sites that are recruiting participants for A study to evaluate isavuconazonium sulfate for the treatment of invasive aspergillosis (IA) or invasive mucormycosis (IM) in pediatric participants? Contact us by filling out your information to the right and we’ll respond to you.

  • A caregiver
  • A healthcare provider
  • A parent
  • A patient
  • A patient advocate
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bosnia And Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • Estonia
  • Finland
  • Former Serbia and Montenegro
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • Mexico
  • Montenegro
  • Morocco
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, Province of China
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

    Locations

    Contact Us
    Contact Us
    Recruiting
    Site ES34003
    Madrid, Spain, 28009
    Recruiting
    St Jude Children's Res Hospital
    Memphis, TN, United States, 38105
    Recruiting
    Children's Mercy Hospital
    Kansas City, Mo, United States, 64108
    Recruiting
    Site BE32002
    Leuven, Belgium, 3000
    Recruiting
    Children's National Medical Center
    Washington, DC, United States, 20010
    Recruiting
    University of California - Los Angeles
    Los Angeles, CA, United States, 90095
    Recruiting
    Nicklaus Children's Hospital
    Miami, FL, United States, 33155
    Recruiting
    Ann & Robert H. Lurie Children's Hospital of Chicago
    Chicago, IL, United States, 60611
    Recruiting
    Children's Hospital of Orange County
    Orange, CA, United States, 92868
    Recruiting
    Miller Children's Hospital
    Long Beach, CA, United States, 90806
    Recruiting
    SUNY Upstate Medical University
    Syracuse, NY, United States, 13210
    Recruiting
    Site ES34001
    Madrid, Spain, 28041
    Recruiting
    Site EU49001
    Munster, Germany, 48149
    Recruiting
    Site BE32001
    Gent, Belgium, 9000
    Recruiting
    University of Louisville
    Louisville, KY, United States, 40202
    Recruiting
    Site EU34002
    Barcelona, Spain, 8035
    Recruiting
    Cincinnati Children's Hospital
    Cincinnati, OH, United States, 45229
    Recruiting
    Children's Hospital, Los Angeles
    Los Angeles, CA, United States, 90027
    Recruiting
    Children's Hospital, LSUHSC, New Orleans
    New Orleans, LA, United States, 70118
    Recruiting
    University Children's Hospital Essen
    Essen, Nordrhein-Westfalen, Germany, 45147

    Frequently Asked Questions

    Are clinical trials only for people with advanced cancer?

    While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

    Will I have to stop my current treatment to participate in a clinical trial?

    Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

    Should I be worried about getting a placebo?

    In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

    Do I need a referral from my doctor to take part in a study?

    Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

    Explore More

    1

    What are clinical trials?

    2

    Why are Clinical Trials Important?

    3

    Why Participate in a Clinical Trial?